tiprankstipranks
Advertisement
Advertisement

AU:AYA Stock Latest News

Artrya advances U.S. Salix rollout and readies coronary flow module for FDA submission
Company AnnouncementsArtrya advances U.S. Salix rollout and readies coronary flow module for FDA submission
1d ago
AYA
Artrya Director Increases Shareholding Through $500,000 Option Exercise
PremiumCompany Announcements
Artrya Director Increases Shareholding Through $500,000 Option Exercise
17d ago
AYA
Artrya seeks ASX quotation for 500,000 new ordinary shares
PremiumCompany Announcements
Artrya seeks ASX quotation for 500,000 new ordinary shares
17d ago
AYA
Artrya Issues New Shares on Director Option Exercise and Files Cleansing Notice
PremiumCompany Announcements
Artrya Issues New Shares on Director Option Exercise and Files Cleansing Notice
17d ago
AYA
Artrya Seeks ASX Quotation for 1.2 Million New Shares
PremiumCompany Announcements
Artrya Seeks ASX Quotation for 1.2 Million New Shares
23d ago
AYA
Artrya Issues Over 1.2 Million New Shares on Option Exercises
PremiumCompany AnnouncementsArtrya Issues Over 1.2 Million New Shares on Option Exercises
23d ago
AYA
Artrya Strengthens Governance With Appointment of New Company Secretary
Premium
Company Announcements
Artrya Strengthens Governance With Appointment of New Company Secretary
1M ago
AYA
Artrya reports lapse of 10,000 performance rights
Premium
Company Announcements
Artrya reports lapse of 10,000 performance rights
2M ago
AYA
Artrya launches non-deal roadshow ahead of Bell Potter healthcare showcase
PremiumCompany Announcements
Artrya launches non-deal roadshow ahead of Bell Potter healthcare showcase
2M ago
AYA
S&P Dow Jones Indices Unveils March 2026 S&P/ASX Index Rebalance
PremiumCompany Announcements
S&P Dow Jones Indices Unveils March 2026 S&P/ASX Index Rebalance
2M ago
AYA
Artrya’s Half-Year Loss Widens Despite Strong Rise in Net Tangible Assets
PremiumCompany Announcements
Artrya’s Half-Year Loss Widens Despite Strong Rise in Net Tangible Assets
2M ago
AYA
Artrya Reports Lapse of 613,334 Performance Rights in Capital Update
PremiumCompany Announcements
Artrya Reports Lapse of 613,334 Performance Rights in Capital Update
2M ago
AYA
Artrya Enlists Dignity Health Arizona and Launches Female-Focused Cohort in SAPPHIRE Heart Study
PremiumCompany AnnouncementsArtrya Enlists Dignity Health Arizona and Launches Female-Focused Cohort in SAPPHIRE Heart Study
3M ago
AYA
Artrya adds HCA Midwest Health to U.S. SAPPHIRE heart disease study
Premium
Company Announcements
Artrya adds HCA Midwest Health to U.S. SAPPHIRE heart disease study
3M ago
AYA
Artrya Names Interim CFO as It Bolsters Leadership for Next Growth Phase
Premium
Company Announcements
Artrya Names Interim CFO as It Bolsters Leadership for Next Growth Phase
3M ago
AYA
Artrya Secures Third U.S. Customer as Cone Health Adopts Salix AI Cardiac Platform
PremiumCompany Announcements
Artrya Secures Third U.S. Customer as Cone Health Adopts Salix AI Cardiac Platform
4M ago
AYA
Artrya Limited Achieves First U.S. Revenue with Salix® Coronary Plaque Module
PremiumCompany Announcements
Artrya Limited Achieves First U.S. Revenue with Salix® Coronary Plaque Module
5M ago
AYA
Artrya Expands U.S. Presence with Northeast Georgia Health System Partnership
PremiumCompany Announcements
Artrya Expands U.S. Presence with Northeast Georgia Health System Partnership
5M ago
AYA
Artrya Limited to Present at Bell Potter Healthcare Conference 2025
PremiumCompany Announcements
Artrya Limited to Present at Bell Potter Healthcare Conference 2025
5M ago
AYA
Artrya to Present at Canaccord Genuity MedTech Forum
PremiumCompany AnnouncementsArtrya to Present at Canaccord Genuity MedTech Forum
5M ago
AYA
Artrya Limited Secures Shareholder Support at AGM
Premium
Company Announcements
Artrya Limited Secures Shareholder Support at AGM
6M ago
AYA
Artrya Limited Advances U.S. Market Entry with FDA Clearances and Strategic Expansion
Premium
Company Announcements
Artrya Limited Advances U.S. Market Entry with FDA Clearances and Strategic Expansion
6M ago
AYA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >